BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20408532)

  • 1. Synthesis and evaluation of 17alpha-arylestradiols as ligands for estrogen receptor alpha and beta.
    Sedlák D; Novák P; Kotora M; Bartůnek P
    J Med Chem; 2010 May; 53(10):4290-4. PubMed ID: 20408532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential response of estrogen receptor subtypes to 1,3-diarylindene and 2,3-diarylindene ligands.
    Clegg NJ; Paruthiyil S; Leitman DC; Scanlan TS
    J Med Chem; 2005 Sep; 48(19):5989-6003. PubMed ID: 16162002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biochemical characterization of a series of 17α-perfluoroalkylated estradiols as selective ligands for estrogen receptor α.
    Eignerová B; Sedlák D; Dracínský M; Bartunek P; Kotora M
    J Med Chem; 2010 Oct; 53(19):6947-53. PubMed ID: 20812681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta.
    Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P
    Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High affinity 17alpha-substituted estradiol derivatives: synthesis and evaluation of estrogen receptor agonist activity.
    Kasiotis KM; Mendorou C; Haroutounian SA; Alexis MN
    Steroids; 2006 Mar; 71(3):249-55. PubMed ID: 16360721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor beta.
    Minutolo F; Bellini R; Bertini S; Carboni I; Lapucci A; Pistolesi L; Prota G; Rapposelli S; Solati F; Tuccinardi T; Martinelli A; Stossi F; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
    J Med Chem; 2008 Mar; 51(5):1344-51. PubMed ID: 18269232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective activation of zebrafish estrogen receptor subtypes by chemicals by using stable reporter gene assay developed in a zebrafish liver cell line.
    Cosnefroy A; Brion F; Maillot-Maréchal E; Porcher JM; Pakdel F; Balaguer P; Aït-Aïssa S
    Toxicol Sci; 2012 Feb; 125(2):439-49. PubMed ID: 22045033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor subtype-selective ligands: asymmetric synthesis and biological evaluation of cis- and trans-5,11-dialkyl- 5,6,11, 12-tetrahydrochrysenes.
    Meyers MJ; Sun J; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 1999 Jul; 42(13):2456-68. PubMed ID: 10395487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
    Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
    J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites.
    De Angelis M; Stossi F; Waibel M; Katzenellenbogen BS; Katzenellenbogen JA
    Bioorg Med Chem; 2005 Dec; 13(23):6529-42. PubMed ID: 16099659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New scaffolds for the design of selective estrogen receptor modulators.
    Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
    Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of estrogen agonism of diaryl 4,5-dihydroisoxazoles, 3-hydroxyketones, 3-methoxyketones, and 1,3-diketones: a compound set forming a 4D molecular library.
    Pulkkinen JT; Honkakoski P; Peräkylä M; Berczi I; Laatikainen R
    J Med Chem; 2008 Jun; 51(12):3562-71. PubMed ID: 18517258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of B-, C-, and D-ring-substituted estradiol carboxylic acid esters as locally active estrogens.
    Labaree DC; Zhang JX; Harris HA; O'Connor C; Reynolds TY; Hochberg RB
    J Med Chem; 2003 May; 46(10):1886-904. PubMed ID: 12723952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrazolo[1,5-a]pyrimidines: estrogen receptor ligands possessing estrogen receptor beta antagonist activity.
    Compton DR; Sheng S; Carlson KE; Rebacz NA; Lee IY; Katzenellenbogen BS; Katzenellenbogen JA
    J Med Chem; 2004 Nov; 47(24):5872-93. PubMed ID: 15537344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising core structure for nuclear receptor ligands: design and synthesis of novel estrogen receptor ligands based on diphenylamine skeleton.
    Ohta K; Chiba Y; Ogawa T; Endo Y
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5050-3. PubMed ID: 18760603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
    Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
    Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-CD estrogens. I. Substituent effects, hormone potency, and receptor subtype selectivity in a new family of flexible estrogenic compounds.
    Wright JS; Shadnia H; Anderson JM; Durst T; Asim M; El-Salfiti M; Choueiri C; Pratt MA; Ruddy SC; Lau R; Carlson KE; Katzenellenbogen JA; O'Brien PJ; Wan L
    J Med Chem; 2011 Jan; 54(2):433-48. PubMed ID: 21190382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta.
    Roelens F; Heldring N; Dhooge W; Bengtsson M; Comhaire F; Gustafsson JA; Treuter E; De Keukeleire D
    J Med Chem; 2006 Dec; 49(25):7357-65. PubMed ID: 17149865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.